WHODRUG
LIVE

Serial Number

79187151

Owner

Uppsala Monitoring Centre

Attorney

Donna J. Bunton

Filing Date

Sep 24, 2015

Add to watchlist:

No watchlists yet
View on USPTO

WHODRUG Trademark

Serial Number: 79187151 • Registration: 5070804

WHODRUG is a trademark filed by Uppsala Monitoring Centre on September 24, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Uppsala Monitoring Centre (8 trademarks)

Box 1051
Uppsala SE-751 40 , SE

Entity Type: 12

Trademark Details

Filing Date

September 24, 2015

Registration Date

November 1, 2016

Published for Opposition

August 16, 2016

Goods & Services

Providing temporary use of online non-downloadable computer software for the management of pharmacovigilance reporting relating to medicines, medical devices, natural remedies, food supplements and cosmetics, as well as other products subject to official approval relating to clinical trials, pharmacovigilance, drug information retrieval, ennobling and standardization and drug classification; providing database search tools, namely, provision of Internet search engines for searching online databases; commissioned research, namely, medical and scientific research using pharmacovigilance databases relating to medicines, medical devices, natural remedies, food supplements and cosmetics, as well as other products subject to official approval relating to clinical trials, pharmacovigilance, drug information retrieval, ennobling and standardization and drug classification

Providing of access to online databases and interactive databases for the management of pharmacovigilance reporting relating to medicines, medical devices, natural remedies, food supplements and cosmetics, as well as other similar products subject to official approval also relating to clinical trials, pharmacovigilance, drug information retrieval, ennobling and standardization and drug classification

Education services, namely, providing classes, seminars and workshops in the fields of pharmacovigilance, clinical trials, drug information retrieval, ennobling and standardization and drug classification; providing of training in the fields of pharmacovigilance, clinical trials, drug information retrieval, ennobling and standardization and drug classification

Downloadable databases in the field of pharmacovigilance for use in information retrieval, reporting and searching in pharmacovigilance reporting databases relating to medicines, medical devices, natural remedies, food supplements and cosmetics, as well as other products subject to official approval relating to clinical trials, pharmacovigilance, drug information retrieval, ennobling and standardization and drug classification; database management software and software for the management, systematization and analysis of pharmacovigilance information relating to medicines, medical devices, natural remedies, food supplements and cosmetics, as well as other products subject to official approval relating to clinical trials, pharmacovigilance, drug information retrieval, ennobling and standardization and drug classification; graphical user interface software (GUI) for public use; computer software for use as an application programming interface (API) for integration in other web pages and/or IT systems

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 1, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
Jun 19, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
May 24, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
May 24, 2023 C75A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 15, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Apr 20, 2023 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 18, 2023 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Oct 28, 2022 NREP
TEAS SECTION 71 & 15 RECEIVED
Sep 30, 2022 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 1, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 25, 2017 FINO
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 10, 2017 OPNX
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 1, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 1, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 16, 2016 NPUB
PUBLISHED FOR OPPOSITION
Aug 16, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 10, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 10, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 27, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 13, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 13, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 13, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 13, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2016 TROA
REFUSAL PROCESSED BY IB
Jun 24, 2016 RFNT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 16, 2016 TCCA
APPLICATION FILING RECEIPT MAILED
Jun 14, 2016 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 9, 2016 RFCS
REFUSAL PROCESSED BY MPU
Jun 9, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 9, 2016 RFCR
NON-FINAL ACTION WRITTEN
Jun 8, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 8, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 2, 2016 REPR